Menu UF Health Home Menu
 

Anna M. McDaniel, Ph.D., R.N., F.A.A.N.

Dean and Professor, UF College of Nursing

University of Florida
PO Box 100197
Gainesville, FL 32610-0197

Telephone: 352-273-6324
Fax: 352-273-6505
Email: annammcdaniel@ufl.edu

Anna M. McDanielAnna M. McDaniel, Ph.D., R.N., F.A.A.N., was named the fifth dean of the University of Florida College of Nursing in the spring of 2013. Previously, Dr. McDaniel served as the Associate Dean for Research at the Indiana University School of Nursing and as a Chancellor’s Professor in both the Schools of Informatics and Nursing. As Associate Dean, she led the School’s Center for Research and Scholarship, whose mission is to support faculty in the development and implementation of research and scholarly activities that advance nursing science through expansion of external funding. She also directed the graduate nursing informatics certificate program.

Dr. McDaniel held a research appointment with the IU Simon Cancer Center and served as Co-Director of the Evaluation Core at IU’s Clinical Translational Science Institute. Dr. McDaniel also previously served as the Director of Evaluation and Outcomes for the Indiana University’s National Center of Excellence in Women’s Health.

In 2004, Dr. McDaniel was elected as a Fellow of the American Academy of Nursing. She received her bachelor’s and master’s degrees in nursing from Ball State University and her Doctor of Nursing Science degree from Indiana University and completed a postdoctoral fellowship in medical informatics from Regenstrief Institute for Health Care in Indianapolis.

Dr. McDaniel’s research focuses on using technology for cancer prevention and control, specifically the treatment of nicotine dependence. Her creative approach to research has earned her both financial support and international recognition from such diverse organizations as the Indiana State Nurses Association, Sigma Theta Tau International and the Midwest Nursing Research Society. Dr. McDaniel is currently the Principal Investigator on a $3.2 million study funded by the National Cancer Institute, which is studying the efficacy of technology for enhancing telephone-based smoking cessation services to prevent smoking relapse and achieve abstinence.